Charlie Sheen claims his old HIV medication left him with ‘borderline dementia’ — but a new drug currently in a clinical trial has eliminated it!
The actor said he did not have any symptoms of dementia until he started taking his first regime of drugs to cure his HIV, but the symptoms disappeared after he joined a phase III clinical trial for “PRO-140” — an experimental injection manufactured in Canada by CytoDyn, Inc.
Sheen started taking PRO-140 last spring, only months after appearing on the “Today” show where he publicly revealed he is HIV-positive.
He has since praised its effects!
“It’s impossibly amazing,” said Sheen. “Personally, I think about how I felt on the day and how I feel today. Wow. Talk about a transformation.”
On numerous occasions, he felt an “emotional and physical transformation” when he switched from a cocktail of drugs to his weekly treatments.
PRO-140 recently ended its third successful clinical trial phase early this year and is now being studied and assessed for FDA approval.
The drug is an “entry and fusion inhibitor” that is injected weekly — made from an antibody instead of synthetic chemicals and protects cells in the immune system from HIV infection.
The process prevents the virus from multiplying while reducing the amount of HIV in the body.
It also aims to do away with the side effects of current anti-HIV drugs like disorientation, fatigue and memory loss.
If approved, the drug could see a mid-2017 or early 2018 release to market.
“I thought for sure I’d be stuck on that cocktail forever, but look at me now,” added Sheen.